Shares in Harvard Bioscience Drop Nearly 9 Percent | GenomeWeb

Shares in Harvard Bioscience fell 8.8 percent for the five-day trading period ended Tuesday, leading all decliners in the BCW Index. Last week, Harvard Bio reported a fourth-quarter loss as investors and customers continue to wait for the sale of the firm's capital equipment business (see briefs). Bio-Rad's shares posted the biggest gain, rising 4 percent for the week.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: genetic study of breast cancer in Egyptian families, mutations linked to cleft lip and palate, and more.

Council Bluffs, Iowa, schools are encouraging more girls to pursue STEM courses, according to the Associated Press.

Because of new open-access requirements, Gates Foundation-funded researchers can't publish in some top journals, Nature News reports.

In Science this week: deletion of one microRNA allows pluripotent stem cells to form embryonic and non-embryonic lineages, and more.